Showing 301 - 320 results of 130,090 for search '(( a e decrease ) OR ( 5 ((((mg decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.55s Refine Results
  1. 301

    Astrocytosis is decreased in the brains of 5XFAD/<i>LDLR</i>-/- and 5XFAD/<i>ApoE-/- LDLR</i>-/- mice. by Loukia Katsouri (348708)

    Published 2013
    “…Quantitation of GFAP positive staining in the hippocampi and cortices showing a decrease in the 5XFAD/<i>LDL</i>-/- and 5XFAD/<i>ApoE</i>-/-<i>LDLR</i>-/- mice compared to the control mice. …”
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308

    Juvenile demyelination leads to a decrease in axonal complexity of PFC PV interneurons. by Sara Hijazi (21656615)

    Published 2025
    “…The data displayed in (D), (E), (G), and (H) can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003421#pbio.3003421.s001" target="_blank">S1 Fig</a>.…”
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313
  14. 314
  15. 315

    DHT increases whereas orchidectomy decreases the weight and cross sectional area of hindlimb muscles. by Young-Eun Yoo (323357)

    Published 2013
    “…<b>A:</b> In WT mice, DHT increased the GN weight by 7% (212.4±8.8 mg), whereas orchidectomy decreased it by 14% (171.4±9.0 mg) compared with control WT mice (198.4±5.5 mg). …”
  16. 316
  17. 317
  18. 318
  19. 319

    Figure 1 Exogenous serotonin inhibits the Dar phenotype and decreases pathogen clearance rates by Rachel Mcmullan (506214)

    Published 2014
    “…<p>Adult wild type animals were exposed to M. nematophilum on plates containing exogenous serotonin and the Dar phenotype was scored in their progeny. Treatment with 3.8mg/ml 5-HT caused a 35% decrease in the number of Dar animals following M. nematophilum infection using standard assay conditions (small lawn) (A). …”
  20. 320

    Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

    Published 2013
    “…<p><b>Panel a:</b> Representative H&E sections (5×) of tibia from tumor-bearing mice treated with control antibody (13C4) or anti-TGFβ antibody (1D11). …”